Discovery To Clinic: CRISPR-Based Therapies And Diagnostics

With CRISPR being a key component of this revolution in treatments and even cures, the industry is seeing a massive increase in demand for clinical-grade guide RNA. Synthego has established itself as a front-runner in this arena with ever-expanding GMP manufacturing capabilities, exemplified by numerous client success stories as well as continuous innovations. Learn about GMP sgRNA and their stringent process and manufacturing controls, along with how Synthego provides assistance throughout early-phase research, process development, and clinical trials for CRISPR-based therapies and diagnostics.